CCM
ABBV icon

Crew Capital Management’s AbbVie ABBV Stock Holding History

Crew Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
8,219
-151
-2% -$33.5K 1.19% 24
2025
Q4 		$1.91M Buy
8,370
+424
+5% +$96.6K 1.2% 21
2025
Q3 		$1.84M Sell
7,946
-14
-0.2% -$2.85K 1.23% 19
2025
Q2 		$1.48M Buy
7,960
+4,424
+125% +$822K 1.06% 23
2025
Q1 		$741K Buy
3,536
+49
+1% +$9.53K 0.6% 63
2024
Q4 		$620K Buy
3,487
+1
+0% +$184 0.51% 69
2024
Q3 		$688K Sell
3,486
-101
-3% -$18.9K 0.55% 67
2024
Q2 		$615K Buy
3,587
+1
+0% +$166 0.49% 67
2024
Q1 		$653K Buy
3,586
+1,306
+57% +$225K 0.53% 65
2023
Q4 		$353K Sell
2,280
-235
-9% -$34.3K 0.36% 55
2023
Q3 		$375K Sell
2,515
-158
-6% -$23.2K 0.4% 50
2023
Q2 		$360K Sell
2,673
-36
-1% -$5.28K 0.41% 56
2023
Q1 		$432K Sell
2,709
-40
-1% -$6.12K 0.62% 36
2022
Q4 		$444K Sell
2,749
-126
-4% -$19.3K 0.64% 36
2022
Q3 		$386K Buy
2,875
+140
+5% +$20.1K 0.53% 49
2022
Q2 		$419K Hold
2,735
– – 0.53% 48
2022
Q1 		$443K Sell
2,735
-33
-1% -$4.79K 0.43% 55
2021
Q4 		$375K Hold
2,768
– – 0.32% 68
2021
Q3 		$299K Hold
2,768
– – 0.28% 77
2021
Q2 		$312K Hold
2,768
– – 0.29% 74
2021
Q1 		$300K Buy
+2,768
New +$296K 0.3% 76

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Crew Capital Management's ABBV Position: Q1 2026 in Review

Crew Capital Management reduced its AbbVie (ABBV) stake by 1.8% in Q1 2026, selling an estimated $33.5K and leaving 8,219 shares worth $1.79M. The position accounts for 1.19% of the portfolio, ranked #24.

Crew Capital Management first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.91M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Crew Capital Management held 8,219 shares of AbbVie worth $1.79M as of Q1 2026.
  • Crew Capital Management sold 151 AbbVie shares in Q1 2026, an estimated $33.5K.
  • AbbVie made up 1.19% of Crew Capital Management's portfolio in Q1 2026, its #24 holding.
  • Crew Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • Crew Capital Management's AbbVie position peaked at $1.91M in Q4 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Crew Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.